The role of intensive AML-specific therapy in treatment of children with RAEB and RAEB-t

Leukemia

Volumn 12, Issue 5, 1998, Pages 652-659

  Creutzig, U ^a   Bender Gotze C ^b   Ritter, J ^a   Zimmermann, M ^a   Stollmann Gibbels, B ^c   Korholz D ^d   Niemeyer, C ^e  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^e UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Children; Myelodysplastic syndromes; RAEB and RAEB t; Treatment

Indexed keywords

CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLAST CELL; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; FEMALE; FEVER; HUMAN; HUMAN CELL; LEUKEMIA REMISSION; MALE; NEUTROPENIA; PNEUMONIA; PRIORITY JOURNAL; REFRACTORY ANEMIA; SEPSIS;

EID: 0031943655     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400987     Document Type: Article

References (10)

1. Aul C, Gattermann N, Schneider W. Age-related incidence and other epidemiological aspects of myelodysplastic syndromes. Br J Haematol 1992; 82: 358-367.
2. Hasle H, Jacobsen BB, Pedersen NT. Myelodysplastic syndromes in childhood: a population based study of nine cases. Br J Haematol 1992; 81: 495-498.
3. Niemeyer C, Aricó M, Basso G, Biondi A, Cantú Rajnoldi A, Creutzig U, Haas O, Harbott J, Hasle H, Kerndrup G, Locatelli F, Mann G, Stollmann-Gibbels B, van't Veer-Korhof E, van Wering E, Zimmermann M and members of the European Working-Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 patients. Blood 1997; 89: 3534-3543.
4. de Witte T, Muus P, De Pauw B, Haanen C. Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia. Cancer 1990; 66: 831-837.
5. Michels SD, Saumur J, Arthur DC, Robison LL, Brunning RD. Refractory anemia with excess of blasts in transformation hematologic and clinical study of 52 patients. Cancer 1989; 64: 2340-2346.
6. O'Donnell MR, Nademanee AP, Snyder DS, Schmidt GM, Parker PM, Bierman PJ, Fahey JL, Stein AS, Krance RA, Stock AD, Forman SJ, Blume KG. Bone marrow transplantation for myelodysplastic and myeloproliferative syndromes. J Clin Oncol 1987; 5: 1822-1826.
7. de Witte T, Zwaan F, Hermans J, Vernant J, Kolb H, Vossen L, Lonnqvist B, Beelen D, Ferrant A, Gmur J, Liu Yin J, Troussard X, Cahn J, Van Lint M, Gratwohl A. Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG). Br J Haematol 1990; 74: 151-155.
8. Longmore G, Guinan EC, Weinstein HJ, Gelber RD, Rappeport JM, Antin JH. Bone marrow transplantation for myelodysplasia and secondary acute nonlymphoblastic leukemia. J Clin Oncol 1990; 8: 1707-1714.
9. Appelbaum FR, Barrall J, Storb R, Fisher LD, Schoch G, Ramberg RE, Shulman H, Anasetti C, Bearman SI, Beatty P, Bensinger WI, Buckner D, Clift RA, Hansen JA, Martin P, Petersen FB, Sanders JE, Singer J, Siewart P, Sullivan KM, Whiterspoon RP, Thomas ED. Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome. Ann Intern Med 1990; 112: 590-597.
10. Nevill TJ, Shepherd JD, Reece DE, Barnett MJ, Nantel SH, Klingemann HG, Phillips GL. Treatment of myelodysplastic syndrome with busulfan-cyclophosphamide conditioning followed by allogeneic BMT. Bone Marrow Transplant 1992; 10: 445-450.